Crystal Structure of the Vα Domain of a T Cell Antigen Receptor
暂无分享,去创建一个
B. Braden | B. A. Fields | B. Ober | E. Malchiodi | M. Lebedeva | X. Ysern | Jin‐Kyoo Kim | X. Shao | E. Ward | R. Mariuzza
[1] R. Huber,et al. Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. , 1974, European journal of biochemistry.
[2] R. Huber,et al. The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. , 1975, Biochemistry.
[3] R. Poljak,et al. Three-dimensional structure of immunoglobulins. , 1979, Annual review of biochemistry.
[4] E. Reinherz,et al. Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones , 1983, The Journal of experimental medicine.
[5] C. Janeway,et al. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells , 1983, The Journal of experimental medicine.
[6] C. Chothia,et al. Domain association in immunoglobulin molecules. The packing of variable domains. , 1985, Journal of molecular biology.
[7] R. Knobler,et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination , 1985, Nature.
[8] L. Hood,et al. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. , 1986, Annual review of immunology.
[9] Lawrence Steinman,et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.
[10] Barry C. Finzel,et al. The use of an imaging proportional counter in macromolecular crystallography , 1987 .
[11] H. Mcdevitt,et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.
[12] Joseph Schlessinger,et al. Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.
[13] H. Band,et al. Biology of the Human γ T‐Cell Receptor , 1991 .
[14] J. Rothbard,et al. Interactions between Immunogenic Peptides and MHC Proteins , 1991 .
[15] L. Steinman,et al. The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. , 1991, Advances in immunology.
[16] M. Davis,et al. Molecular components of T-cell recognition. , 1992, Annual review of immunology.
[17] Ursula Esser,et al. Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics , 1992, Nature.
[18] D. Wiley,et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.
[19] B. Seed,et al. T cell activation by clustered tyrosine kinases , 1993, Cell.
[20] R J Fletterick,et al. Crystal structure of a catalytic antibody with a serine protease active site. , 1994, Science.
[21] Dan R. Littman,et al. Signal transduction by lymphocyte antigen receptors , 1994, Cell.
[22] P Bork,et al. The immunoglobulin fold. Structural classification, sequence patterns and common core. , 1994, Journal of molecular biology.
[23] Ronald N. Germain,et al. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.
[24] J. Navaza,et al. AMoRe: an automated package for molecular replacement , 1994 .
[25] C Chothia,et al. Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. , 1994, Journal of molecular biology.
[26] R. Poljak,et al. Crystallization and Preliminary X-ray Diffraction Study of a Bacterially Produced T-cell Antigen Receptor Vα Domain , 1994 .
[27] R. Mariuzza,et al. Crystal structure of the beta chain of a T cell antigen receptor. , 1995, Science.
[28] Mutational analysis of two DR alpha residues involved in dimers of HLA-DR molecules. , 1995, Journal of immunology.
[29] C. Heldin,et al. Dimerization of cell surface receptors in signal transduction , 1995, Cell.
[30] A. Casrouge,et al. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness , 1995, The Journal of experimental medicine.